Bayer welcomes ruling against BASF claim on seed businesses

The logo of Bayer AG is pictured at the facade of the historic headquarters of the German pharmaceutical and chemical maker in Leverkusen, Germany, April 27, 2020. REUTERS/Wolfgang Rattay/File Photo Register now for FREE unlimited access to Reuters.com Register BERLIN, Aug 12 (Reuters) – Bayer (BAYGn.DE) on Friday welcomed a decision by an arbitration court … Read more

J&J to end global sales of talc-based baby powder

Aug 11 (Reuters) – Johnson & Johnson ( JNJ.N ) will stop selling talc-based baby powder globally in 2023, the drugmaker said on Thursday, more than two years after it ended US sales of a product that drew thousands of consumer safety lawsuits. “As part of a worldwide portfolio assessment, we have made the commercial … Read more

Senate Finance Committee looks at Amgen taxes, widening drugmaker probe

An Amgen sign is seen at the company’s office in South San Francisco, California, October 21, 2013. REUTERS/Robert Galbraith Register now for FREE unlimited access to Reuters.com Register NEW YORK, Aug 11 (Reuters) – The US Senate Finance Committee is widening its investigation into the tax practices of US drugmakers to include Amgen Inc ( … Read more

Novavax cuts sales forecast for the year as vaccine sales slow

Vials with a sticker reading, “COVID-19 / Coronavirus vaccine / Injection only” and a medical syringe are seen in front of a displayed Novavax logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration Register now for FREE unlimited access to Reuters.com Register Aug 8 (Reuters) – Novavax Inc on Monday cut its full-year revenue … Read more

TSX index slips after US, Canada jobs data

A Toronto Stock Exchange sign adorns a doorway at the Exchange Tower building in Toronto, Ontario, Canada January 23, 2019. REUTERS/Chris Helgren Register now for FREE unlimited access to Reuters.com Register TSX off 0.1% Canada sheds jobs for the second month in a row Pot producer Canopy Growth slides on another quarterly loss Aug 5 … Read more

Green Thumb’s quarterly cannabis sales hit New Jersey high

FILE PHOTO – Marijuana plants for the adult recreational market sit on the back of a tractor for planting at Hepworth Farms in Milton, New York, US, July 15, 2022. REUTERS/Shannon Stapleton Register now for FREE unlimited access to Reuters.com Register Aug 3 (Reuters) – Green Thumb Industries Inc (GTII.CD) posted a more than 14% … Read more

Moderna maintains vaccine sales view as demand from low-income nations eases

Syringes with needles are seen in front of a displayed Moderna logo in this illustration taken November 27, 2021. REUTERS/Dado Ruvic/Illustration/File Photo Register now for FREE unlimited access to Reuters.com Register Aug 3 (Reuters) – Moderna Inc (MRNA.O) on Wednesday retained its full-year sales outlook for COVID-19 shot at $21 billion due to decreasing orders … Read more

CVS Health lifts forecast as insurance business, COVID tests boost Q2 profit

CVS Health logo is seen displayed in this illustration taken, May 3, 2022. REUTERS/Dado Ruvic/Illustration Register now for FREE unlimited access to Reuters.com Register Aug 3 (Reuters) – CVS Health Corp (CVS.N) on Wednesday raised its annual profit forecast after strength in its insurance business and sales of COVID-19 over-the-counter test kits helped boost quarterly … Read more

Regeneron quarterly profit slumps as COVID antibody sales dry up

The Regeneron Pharmaceuticals company logo is seen on a building at the company’s Westchester campus in Tarrytown, New York, US September 17, 2020. Picture taken September 17, 2020. REUTERS/Brendan McDermid/File Photo Register now for FREE unlimited access to Reuters.com Register Aug 3 (Reuters) – Regeneron Pharmaceuticals (REGN.O) reported a 72.5% fall in quarterly profit on … Read more

Merck quarterly profit tops Wall Street view on strong Keytruda sales

Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey, US, November 13, 2021. REUTERS/Andrew Kelly/File Photo Register now for FREE unlimited access to Reuters.com Register July 28 (Reuters) – Merck & Co (MRK.N) on Thursday reported higher-than-expected second-quarter earnings and revenue on strong sales of its blockbuster cancer drug Keytruda. The … Read more